Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Arthur Kavanaugh

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

scholarly article by Daniel Aletaha et al published 10 August 2010 in Arthritis and Rheumatism

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

scientific article

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

scientific article

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

article

A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis

scientific article

A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria

scientific article published on 15 February 2013

A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist

scientific article published on 15 September 2014

A pilot study of rituximab in immune-mediated inner ear disease

scientific article published on 27 October 2010

A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.

scientific article published in December 2005

Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

scientific article published on 26 September 2017

Achilles enthesitis defined by ultrasound is not associated with clinical enthesitis in patients with psoriatic arthritis

scientific article published on 16 August 2017

Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: subanalysis of the PREMIER study

scientific article

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

scientific article

Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial

scientific article published on 01 March 2003

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis ⬇️

scientific article published on September 22, 2010

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents

scientific article

Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis

scientific article published on 04 June 2010

Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research

scientific article published on 03 February 2020

Association Between Enthesitis and Health-related Quality of Life in Psoriatic Arthritis in Biologic-naive Patients from 2 Phase III Ustekinumab Trials

scientific article published on 01 April 2019

Association of anemia and physical disability among patients with rheumatoid arthritis.

scientific article published on 15 October 2007

Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.

scientific article

Bedside to bench: defining the immunopathogenesis of psoriatic arthritis

scientific article published on 04 September 2019

Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry

scientific article published on 8 March 2017

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis

scientific article published on 10 April 2014

Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial

scientific article published on 01 February 2020

Biologic discontinuation studies: a systematic review of methods

scientific article published on 30 May 2013

Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008.

scientific article

Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3.

scientific article published on 13 July 2017

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example

scientific article

Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

scientific article

Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.

scientific article published on 4 April 2017

Clinical Consequences of Delayed Addition of Adalimumab to Methotrexate Therapy Over 5 Years in Patients with Rheumatoid Arthritis ⬇️

scientific article published on 01 February 2011

Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.

scientific article published on 15 June 2017

Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study

scientific article

Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study).

scientific article

Clinical remission in patients with active psoriatic arthritis treated with adalimumab and correlations in joint and skin manifestations

scientific article published on April 2015

Clinical, Functional, and Radiographic Benefits of Longterm Adalimumab Plus Methotrexate: Final 10-year Data in Longstanding Rheumatoid Arthritis ⬇️

scientific article published on July 1, 2013

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA s

scientific article published on 5 May 2012

Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study

scientific article published in December 2013

Clinically meaningful improvement in work productivity loss in active psoriatic arthritis: post-hoc analysis of SPIRIT-P1 and SPIRIT-P2 trials

scientific article published on 11 May 2020

Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial

scientific article published on August 2004

Comparison of composite measures of disease activity in psoriatic arthritis using data from an interventional study with golimumab

scientific article

Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis

scientific article published on 01 April 2008

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

scientific article

Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis? ⬇️

scientific article

Consensus guidelines for the management of plaque psoriasis.

scientific article

Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry

scientific article published on 29 September 2018

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

scientific article published on 28 September 2015

Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry

scientific article

Disease Activity, Physical Function, and Radiographic Progression After Longterm Therapy with Adalimumab Plus Methotrexate: 5-Year Results of PREMIER ⬇️

scientific article published on October 1, 2010

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

scientific article published on 04 June 2018

Documentation of off-label use of biologics in Rheumatoid Arthritis ⬇️

scientific article published on April 1, 2013

Early effects of tocilizumab in the treatment of moderate to severe active rheumatoid arthritis: a one-week sub-study of a randomised controlled trial (Rapid Onset and Systemic Efficacy [ROSE] Study)

scientific article published on January 10, 2013

Editorial: pregnancy and rheumatoid arthritis - do not let the perfect become the enemy of the good

scientific article published in May 2014

Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosus

scientific article published in October 2002

Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate

scientific article

Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis

scientific article

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes

scientific article published on 23 March 2018

Effect of high-intensity interval training on cardiovascular disease risk factors and body composition in psoriatic arthritis: a randomised controlled trial

article

Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis.

scientific article published in September 2006

Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial

scientific article published on October 2010

Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kinase Inhibitor, on Health-related Quality of Life in Patients with Active Rheumatoid Arthritis: Analyses of Patient-reported Outcomes from a Randomized, Double-blind, Placebo-controlled Trial ⬇️

scientific article published on February 1, 2013

Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial

scientific article published on 18 September 2020

Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group stud

scientific article published in December 2014

Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy

scientific article published on 15 July 2008

Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials

scientific article published on 01 February 2020

Efficacy and Safety of Intravenous Golimumab through 1 Year in Patients with Active Psoriatic Arthritis

scientific article published on 12 April 2019

Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies

scientific article

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phas

scientific article

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

scientific article published on 13 June 2013

Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2).

scientific article published on 20 April 2016

Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study

scientific article published on 15 June 2016

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study ⬇️

scientific article published on September 26, 2011

Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2

scientific article published on 18 August 2019

Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase I

scientific article published on November 2009

Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study

scientific article published on 19 October 2020

Evaluation of an instrument assessing influence of Gout on health-related quality of life

scientific article published on 15 October 2008

Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis

scientific article published on 26 February 2020

Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents

scientific article

Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy

scientific article published on 21 July 2015

Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout

scientific article published on 17 August 2017

Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid arthritis

scientific article published in May 2004

GRAPPA 2018 Project Report

scientific article published on 01 June 2019

GRAPPA Treatment Recommendations: Updates and Methods

scientific article published on 01 June 2020

GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. ⬇️

scientific article published on 28 November 2017

Genetic markers associated with clinical and radiographic response in adalimumab plus methotrexate- or methotrexate-treated rheumatoid arthritis patients in OPTIMA

scientific article published on 09 April 2019

Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial

scientific article published in August 2012

Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

scientific article

Gout disease-specific quality of life and the association with gout characteristics ⬇️

scientific article published on March 1, 2010

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

scientific article

Hand Bone Loss in Patients with Psoriatic Arthritis: Posthoc Analysis of IMPACT II Data Comparing Infliximab and Placebo ⬇️

scientific article published on June 15, 2013

High impact of burnout on rheumatology practitioners

scientific article published on 01 April 2020

Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.

scientific article published on January 2015

Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008.

scientific article published in February 2010

Immunomodulator therapy: monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins

scientific article published on 29 December 2009

Impact of High-Intensity Interval Training on Disease Activity and Disease in Patients With Psoriatic Arthritis: A Randomized Controlled Trial

scientific article published on 01 April 2019

Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials

scientific article published on 14 September 2017

Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study

scientific article published on November 2015

Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies

scientific article published on 10 February 2020

Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

scientific article published on 01 July 2018

Information technology in rheumatology

scientific article

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial

scientific article published on 6 March 2020

International Treatment Recommendations Update: A Report from the GRAPPA 2016 Annual Meeting

scientific article

International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis

scientific article published on 1 September 2009

International spondyloarthritis interobserver reliability exercise - the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis

article

International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures

scientific article published in July 2007

Is a 12-week trial sufficient to evaluate clinical responses to etanercept or MTX treatment in early RA?

scientific article published on 24 February 2010

Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks

scientific article published on 19 November 2018

Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses.

scientific article

Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials

scientific article published on 25 July 2020

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis

scientific article published on 10 May 2019

Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis

scientific article published on 15 January 2015

Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label exten

scientific article

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial.

scientific article published on 19 June 2015

Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations

scientific article published on 10 November 2016

Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab

scientific article published on 12 September 2012

Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial

scientific article published on 15 October 2012

Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population

scientific article

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis. ⬇️

scientific article published on 11 January 2017

Osteoporosis in psoriatic arthritis: a cross-sectional study of an outpatient clinic population

scientific article published on 17 June 2018

Outcome measures in psoriatic arthritis

scientific article published on 1 May 2007

Outcome measures in psoriatic arthritis

scientific article published on 1 November 2005

Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.

scientific article

Patient-derived joint counts are a potential alternative for determining Disease Activity Score

scientific article

Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial

scientific article

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

scientific article

Perceptions of disease and health-related quality of life among patients with gout

scientific article published on 23 March 2009

Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist

scientific article published on July 1, 2013

Predicting future response to certolizumab pegol in rheumatoid arthritis patients: Features at 12 weeks associated with low disease activity at 1 year ⬇️

scientific article published on May 1, 2012

Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial ⬇️

scientific article published on October 13, 2011

Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial

scientific article published on 18 July 2017

Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor

scientific article published on 15 January 2019

Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate

scholarly article by Josef S Smolen et al published November 2018 in Annals of the Rheumatic Diseases

Pregnancy: Data, Outcomes, and Treatment Paradigms in Rheumatology

scientific article published in August 2015

Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases

scientific article published in March 2015

Proceedings of the 2011 Rheumatology Winter Clinical Symposia—Arthur Kavanaugh, MD and John J. Cush, MD (Proceedings Editors) [Course Directors: Arthur Kavanaugh, MD, George Martin, MD] ⬇️

scientific article published on April 1, 2011

Proceedings of the 2012 Rheumatology Winter Clinical Symposia ⬇️

scientific article published on June 1, 2012

Proceedings of the 2013 Rheumatology Winter Clinical Symposia ⬇️

scientific article published on June 1, 2013

Proceedings of the GRAPPA 2016 Retreat

scientific article

Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey ⬇️

scientific article published on 29 February 2016

Qualifying unmet needs and improving standards of care in psoriatic arthritis

scientific article

Quantitative biomarker analysis of synovial gene expression by real-time PCR

scientific article

Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab

scientific article published on 01 March 2019

Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial

scientific article published on 15 February 2019

Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled Study

scientific article published on 16 March 2015

Radiographic progression is less in psoriatic arthritis achieving a good response to treatment: data using newer composite indices of disease activity ⬇️

scientific article

Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized cont

scientific article

Reading and interpreting economic evaluations in rheumatoid arthritis: an assessment of selected instruments for critical appraisal

scientific article

Response to: 'Biologic discontinuation studies: a systematic review of methods' by van der Maas et al.

scientific article

Rheumatic disease in the elderly: rheumatoid arthritis

scientific article

Rheumatic disease in the elderly: rheumatoid arthritis

scientific article published on 01 February 2007

Rheumatoid arthritis

scientific article published on 08 February 2018

Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis

scientific article published on 6 May 2010

Safety and Efficacy of Intravenous Golimumab in Patients With Active Psoriatic Arthritis: Results Through Week Twenty-Four of the GO-VIBRANT Study

scientific article published on 13 August 2017

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

scientific article published on October 2015

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study

scientific article published on 14 November 2019

Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study

scientific article published on October 2016

Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

scientific article published on 01 May 2020

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article

Standardization of joint examination technique leads to a significant decrease in variability among different examiners

scientific article published on 15 February 2010

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

scientific article published on 01 April 2005

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.

scientific article

Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA.

scientific article

Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis. ⬇️

scientific article published on 16 November 2017

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report

scientific article

The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies

scientific article published on 21 May 2019

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

scientific article published on 01 May 2006

The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis

scientific article published on 01 October 2004

The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

scientific article

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

scientific article published on 01 June 2002

The when and how of biologic agent withdrawal in rheumatoid arthritis: learning from large randomised controlled trials

scientific article published on July 1, 2013

Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies.

scientific article published on 27 June 2018

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

scientific article published on 18 March 2013

Tocilizumab versus adalimumab for rheumatoid arthritis – Authors’ reply ⬇️

scientific article published on August 3, 2013

Treat to target: a proposed new paradigm for the management of Crohn's disease

scientific article published on 10 September 2013

Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerations. Introduction

scientific article published on 01 July 2012

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force ⬇️

scientific article

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

scientific article published on 08 June 2013

Treatment disparity related to race/ethnicity and education in rheumatoid arthritis patients: comment on the article by Constantinescu et al.

scientific article published in August 2009

Treatment of Psoriatic Arthritis with Tumor Necrosis Factor Inhibitors: Longer-term Outcomes Including Enthesitis and Dactylitis with Golimumab Treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL) ⬇️

scientific article published on July 1, 2012

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

scientific article

Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial

scientific article published in November 2008

Treatment to Target in Psoriatic Arthritis with Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

scientific article published on 7 January 2020

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

scientific article published on 15 March 2008

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey

scientific article published on 30 December 2015

Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.

scientific article published on 18 April 2016

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.

scientific article published on April 2013

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting ⬇️

scientific article published on September 1, 2013

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting

scientific article published in September 2015

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

scientific article published on September 2016

Use of data from multiple registries in studying biologic discontinuation: challenges and opportunities

scientific article

Use of the 28-Joint Count Yields Significantly Higher Concordance Between Different Examiners Than the 66/68-Joint Count ⬇️

scientific article published on 01 June 2012

Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic Arthritis

scientific article published on 2 August 2016

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

scientific article published on 11 February 2009

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, pla

scientific article

Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study

scientific article published on 15 April 2009

Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases ⬇️

scientific article published on 7 November 2017

Paulina is supported by:

About Paulina

Help